The future of melanoma detection: Targeted screening, technology and the changing landscape | ACCREDITED | 42 min 1

How will melanoma detection change over the next decade?

In this episode from MIA's podcast Melanoma Insights for Professionals, our multidisciplinary experts explore how targeted screening, personalised risk assessment, advanced imaging, artificial intelligence and evolving models of care could transform the way melanoma is detected.

The discussion provides insight into how we can identify those most likely to benefit from screening, reduce unnecessary biopsies and surveillance, and make better use of Australia's limited healthcare workforce and resources.

This podcast is suitable for dermatologists, skin cancer doctors, GPs, nurses, public health researchers and other healthcare professionals.

• Identify key risk factors for melanoma and describe how risk stratification can be used to inform personalised prevention, skin checks and surveillance.
• Discuss the potential benefits, harms and limitations of targeted melanoma screening and emerging detection technologies, including imaging and artificial intelligence.
• Discuss the implications of evolving melanoma detection strategies for general practice, including workforce requirements, models of care, triage and referral pathways.

• Yan S, Yu Z, Primiero C, Vico-Alonso C, et al. A multimodal vision foundation model for clinical dermatology. Nat Med. 2025 Aug;31(8):2691-2702.
• Snoswell CL, Caffery LJ, Whitty JA, et al. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia. JAMA Dermatol. 2018;154(6):694–700.

• MIA's Melanoma Risk Prediction Calculators
• More information on the Roadmap for a National Targeted Melanoma Screening Program.

Prof Pascale Guitera
Dermatologist
Director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital | Professorial Research Fellow, The University of Sydney | Faculty Member, Melanoma Institute Australia
Declaration of Interest

Prof Rachael Morton
Director of Health Economics and Health Technology Assessment
The Sydney Clinical Trials Centre, The University of Sydney | Faculty Member, Melanoma Institute Australia
Declaration of Interest

Prof Victoria Mar
Dermatologist
Director of the Victorian Melanoma Service at The Alfred | Professor of DermatoOncology, School of Public Health and Preventive Medicine, Monash University

Dr Amelia Smit
Senior Research Fellow in Cancer Epidemiology
The Daffodil Centre, The University of Sydney and Cancer Council NSW

Danielle Fischer
Education Program Manager, Melanoma Institute Australia
Declaration of Interest

A certificate of completion will be issued upon completion of listening to this podcast for your CPD records. If you have a member number for RACGP or SkinPro CPD in your profile, we will upload the CPD hours on your behalf at regular intervals.

This activity (1671208) is allocated 0.5 EA CPD hours in the RACGP CPD Program.

This activity (10124) is allocated 0.5 EA CPD hours in the SkinPro CPD Program.

Please note that this podcast was accurate at the time of recording (September 2026) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

• Module1.1
  The future of melanoma detection: Targeted screening, technology and the changing landscape | ACCREDITED | 42 min
  42 min